Bullish on biotech in '03. That's the take on the industry by Banc of America Securities, a viewpoint it attributes to a season of earnings re-acceleration and late-stage data, prompting the firm to label 2003 as potentially "the biggest product year ever for biotech." (BioWorld Today)